BIMI — BIMI Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $1.75m
- $11.83m
Annual income statement for BIMI Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.158 | 12.8 | 21.3 | 11.8 |
Cost of Revenue | |||||
Gross Profit | 0 | -0.146 | 11.7 | 2.43 | 1.95 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.213 | 1.87 | 16.7 | 53.2 | 27.2 |
Operating Profit | -0.213 | -1.71 | -3.81 | -31.9 | -15.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.213 | -2.27 | -3.35 | -34.7 | -21.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.213 | -2.27 | -3.79 | -34.7 | -21.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -16.8 | -4.44 | -2 | -35 | -22.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.8 | -4.44 | -2 | -35 | -22.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.005 | -13.8 | 10 | -33.1 | -6.83 |